CATECHOL-O-METHYLTRANSFERASE INHIBITION BY U-0521 INCREASES STRIATAL UTILIZATION OF LEVODOPARECHES A; DE HUA JIANG; FAHN S et al.1982; NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY; ISSN 0028-1298; DEU; DA. 1982; VOL. 320; NO 1; PP. 34-37; BIBL. 29 REF.Article

Two mechanisms of ³H-catecholamine accumulation in rabbit aorta media differentiated by sensitivity to temperature and corticosteroneSWEET, W. D; LEVIN, J. A.Blood vessels. 1983, Vol 20, Num 6, pp 265-282, issn 0303-6847Article

EFFECT OF A CATECHOL-O-METHYL TRANSFERASE INHIBITOR, U-0521, WITH LEVODOPA ADMINISTRATIONFAHN S; COMI R; SNIDER SR et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 7; PP. 1221-1225; BIBL. 34 REF.Article

Extraneuronal uptake inhibitor U-0521 decreases contractile responses in rat vas deferensRICE, P. J; ABRAHAM, S. T; HUANG, N.-Y et al.General pharmacology. 1997, Vol 29, Num 3, pp 437-439, issn 0306-3623Article